News

Top
News
KYORIN Pharmaceutical and Synmosa Biopharma Corporation Sign License Agreement of Imidafenacin in Taiwan

KYORIN Pharmaceutical and Synmosa Biopharma Corporation Sign License Agreement of Imidafenacin in Taiwan

August 31, 2015

Please see the PDF file below for details.

KYORIN Pharmaceutical and Synmosa Biopharma Corporation Sign License Agreement of Imidafenacin in Taiwan [ 25.4 KB ]